Previously, Regev-Yochay et al.demonstrated the competitive advantage of having spxB in a nasopharyngeal colonization model (52). It has been reported that spxB inactivation in a capsular pneumococcal serotype 2 strain reduces its adherence to alveolar epithelial cells (28).